GB1421964A - Process for the production of sustained release pharmaceutical preparations - Google Patents

Process for the production of sustained release pharmaceutical preparations

Info

Publication number
GB1421964A
GB1421964A GB2235973A GB2235973A GB1421964A GB 1421964 A GB1421964 A GB 1421964A GB 2235973 A GB2235973 A GB 2235973A GB 2235973 A GB2235973 A GB 2235973A GB 1421964 A GB1421964 A GB 1421964A
Authority
GB
United Kingdom
Prior art keywords
sustained release
release pharmaceutical
binder
cellulose
processing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB2235973A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoires Servier SAS
Original Assignee
Laboratoires Servier SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoires Servier SAS filed Critical Laboratoires Servier SAS
Publication of GB1421964A publication Critical patent/GB1421964A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
GB2235973A 1972-05-10 1973-05-10 Process for the production of sustained release pharmaceutical preparations Expired GB1421964A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7216616A FR2183546B1 (US06486227-20021126-C00005.png) 1972-05-10 1972-05-10

Publications (1)

Publication Number Publication Date
GB1421964A true GB1421964A (en) 1976-01-21

Family

ID=9098254

Family Applications (1)

Application Number Title Priority Date Filing Date
GB2235973A Expired GB1421964A (en) 1972-05-10 1973-05-10 Process for the production of sustained release pharmaceutical preparations

Country Status (17)

Country Link
US (1) US3950508A (US06486227-20021126-C00005.png)
JP (1) JPS5526124B2 (US06486227-20021126-C00005.png)
AR (1) AR203268A1 (US06486227-20021126-C00005.png)
BE (1) BE799331A (US06486227-20021126-C00005.png)
CA (1) CA1041906A (US06486227-20021126-C00005.png)
DD (1) DD104027A5 (US06486227-20021126-C00005.png)
DE (1) DE2323686A1 (US06486227-20021126-C00005.png)
DK (1) DK137706B (US06486227-20021126-C00005.png)
FI (1) FI56623C (US06486227-20021126-C00005.png)
FR (1) FR2183546B1 (US06486227-20021126-C00005.png)
GB (1) GB1421964A (US06486227-20021126-C00005.png)
HU (1) HU168307B (US06486227-20021126-C00005.png)
IL (1) IL42232A (US06486227-20021126-C00005.png)
IN (1) IN139518B (US06486227-20021126-C00005.png)
NL (1) NL158388B (US06486227-20021126-C00005.png)
OA (1) OA04380A (US06486227-20021126-C00005.png)
ZA (1) ZA733188B (US06486227-20021126-C00005.png)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5556639A (en) * 1991-01-30 1996-09-17 Glaxo Wellcome Inc. Water-dispersible tablets
US5629016A (en) * 1991-01-30 1997-05-13 Glaxo Wellcome Inc. Water-dispersible tablets
US5698226A (en) * 1993-07-13 1997-12-16 Glaxo Wellcome Inc. Water-dispersible tablets
US5698221A (en) * 1992-07-27 1997-12-16 Patel; Suryakant Dahyabhai Water-dispersible tablets
US7585521B2 (en) 2000-02-21 2009-09-08 Australian Nuclear Science & Technology Organisation Controlled release ceramic particles, compositions thereof, processes of preparation and methods of use

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3923939A (en) * 1974-06-07 1975-12-02 Alza Corp Process for improving release kinetics of a monolithic drug delivery device
GB1576376A (en) * 1977-03-30 1980-10-08 Benzon As Alfred Multiple-unit drug dose
US4264573A (en) * 1979-05-21 1981-04-28 Rowell Laboratories, Inc. Pharmaceutical formulation for slow release via controlled surface erosion
US4226849A (en) * 1979-06-14 1980-10-07 Forest Laboratories Inc. Sustained release therapeutic compositions
US4547358A (en) * 1980-05-06 1985-10-15 Mead Johnson & Company Sustained release tablet containing at least 95 percent theophylline
US4465660A (en) * 1981-04-01 1984-08-14 Mead Johnson & Company Sustained release tablet containing at least 95 percent theophylline
US4985017A (en) * 1981-07-13 1991-01-15 Alza Corporation Parenteral therapeutical system comprising drug cell
EP0094116A3 (en) * 1982-05-06 1984-08-01 The Procter & Gamble Company Therapeutic granules
US4415547A (en) * 1982-06-14 1983-11-15 Sterling Drug Inc. Sustained-release pharmaceutical tablet and process for preparation thereof
HU187215B (en) * 1983-01-26 1985-11-28 Egyt Gyogyszervegyeszeti Gyar Method for producing pharmaceutical product of high actor content and prolonged effect
DE3435325A1 (de) * 1983-04-09 1986-04-17 Nikken Chemicals Co., Ltd., Tokio/Tokyo Langzeitwirkende theophyllin-tablette und verfahren zu deren herstellung
WO1984004674A1 (en) * 1983-05-31 1984-12-06 Jang Choong Gook Dry direct compression compositions for controlled release dosage forms
JPS60104805A (ja) * 1983-11-09 1985-06-10 Nippon Ferrite Ltd エア抜き装置
JPS60104804A (ja) * 1983-11-09 1985-06-10 Nippon Ferrite Ltd エア抜き装置
US4590062A (en) * 1984-04-16 1986-05-20 Tech Trade Corp. Dry direct compression compositions for controlled release dosage forms
US4772475A (en) * 1985-03-08 1988-09-20 Yamanouchi Pharmaceutical Co., Ltd. Controlled-release multiple units pharmaceutical formulation
GB8521350D0 (en) * 1985-08-28 1985-10-02 Euro Celtique Sa Analgesic composition
US4810501A (en) * 1986-06-17 1989-03-07 Warner-Lambert Company Sustained release pharmaceutical preparations
US4994276A (en) * 1988-09-19 1991-02-19 Edward Mendell Co., Inc. Directly compressible sustained release excipient
US4837030A (en) * 1987-10-06 1989-06-06 American Cyanamid Company Novel controlled release formulations of tetracycline compounds
US4851226A (en) * 1987-11-16 1989-07-25 Mcneil Consumer Products Company Chewable medicament tablet containing means for taste masking
US5135757A (en) * 1988-09-19 1992-08-04 Edward Mendell Co., Inc. Compressible sustained release solid dosage forms
US5128143A (en) * 1988-09-19 1992-07-07 Edward Mendell Co., Inc. Sustained release excipient and tablet formulation
US5169639A (en) * 1988-09-19 1992-12-08 Edward Mendell Co., Inc. Controlled release verapamil tablets
US5472711A (en) * 1992-07-30 1995-12-05 Edward Mendell Co., Inc. Agglomerated hydrophilic complexes with multi-phasic release characteristics
CA2150119C (en) * 1992-11-30 2005-03-15 Robert C. Cuca Tastemasked pharmaceutical materials
NZ260408A (en) * 1993-05-10 1996-05-28 Euro Celtique Sa Controlled release preparation comprising tramadol
KR100354702B1 (ko) * 1993-11-23 2002-12-28 유로-셀티크 소시에떼 아노뉨 약학조성물의제조방법및서방형조성물
US5891471A (en) * 1993-11-23 1999-04-06 Euro-Celtique, S.A. Pharmaceutical multiparticulates
US5843480A (en) * 1994-03-14 1998-12-01 Euro-Celtique, S.A. Controlled release diamorphine formulation
GB9422154D0 (en) * 1994-11-03 1994-12-21 Euro Celtique Sa Pharmaceutical compositions and method of producing the same
US5965161A (en) 1994-11-04 1999-10-12 Euro-Celtique, S.A. Extruded multi-particulates
FR2760190B1 (fr) * 1997-02-28 1999-04-09 Adir Composition pharmaceutique pour la liberation programmee de dexfenfluramine
IN186245B (US06486227-20021126-C00005.png) 1997-09-19 2001-07-14 Ranbaxy Lab Ltd
US6375957B1 (en) 1997-12-22 2002-04-23 Euro-Celtique, S.A. Opioid agonist/opioid antagonist/acetaminophen combinations
HU1500214D0 (hu) 1997-12-22 2002-03-28 Euro Celtique Sa Opioid agonista és antagonista hatóanyagot tartalmazó gyógyszerkészítmény
DE19918325A1 (de) 1999-04-22 2000-10-26 Euro Celtique Sa Verfahren zur Herstellung von Arzneiformen mit regulierter Wirkstofffreisetzung mittels Extrusion
ES2361148T3 (es) 2001-05-11 2011-06-14 Endo Pharmaceuticals Inc. Forma de dosificación de opioides de liberación controlada resistente al abuso.
EP2425823A1 (en) 2002-04-05 2012-03-07 Euro-Celtique S.A. Pharmaceutical preparation containing oxycodone and naloxone
MXPA06000702A (es) * 2003-07-23 2006-04-11 Perrigo L Co Composicion que contiene fibra celulosica.
AU2005227090B2 (en) * 2004-03-22 2010-12-09 Abbott Laboratories Gmbh Oral pharmaceutical compositions of lipase-containing products, in particular of pancreatin, containing surfactants
EP1604667A1 (en) * 2004-06-08 2005-12-14 Euro-Celtique S.A. Opioids for the treatment of the restless leg syndrome
EP1604666A1 (en) * 2004-06-08 2005-12-14 Euro-Celtique S.A. Opioids for the treatment of the Chronic Obstructive Pulmonary Disease (COPD)
JP5704789B2 (ja) * 2005-01-28 2015-04-22 ユーロ−セルティーク エス．エイ． 耐アルコール性剤形
EP1695700A1 (en) * 2005-02-28 2006-08-30 Euro-Celtique S.A. Dosage form containing oxycodone and naloxone
EP1702558A1 (en) 2005-02-28 2006-09-20 Euro-Celtique S.A. Method and device for the assessment of bowel function
UA93384C2 (ru) * 2005-07-29 2011-02-10 Солвей Фармасьютикалс Гмбх Способ получения стерилизированного порошкообразного панкреатина
US11266607B2 (en) * 2005-08-15 2022-03-08 AbbVie Pharmaceuticals GmbH Process for the manufacture and use of pancreatin micropellet cores
US9198871B2 (en) * 2005-08-15 2015-12-01 Abbott Products Gmbh Delayed release pancreatin compositions
US10072256B2 (en) * 2006-05-22 2018-09-11 Abbott Products Gmbh Process for separating and determining the viral load in a pancreatin sample
US20070286903A1 (en) * 2006-06-13 2007-12-13 Becicka Brian T Composition and method for taste masking
US20090130063A1 (en) * 2007-11-15 2009-05-21 Solvay Pharmaceuticals Gmbh Process for separating and determining the viral load in a pancreatin sample
EP2317991B1 (en) * 2008-07-07 2017-05-03 Euro-Celtique S.A. Use of opioid antagonists for treating urinary retention
MX347106B (es) 2009-03-10 2017-04-12 Euro-Celtique S A * Coposiciones farmacéuticas de liberación inmediata que comprenden oxicodona y naloxona.
CN105517551A (zh) 2013-07-23 2016-04-20 欧洲凯尔特公司 用于在患有疼痛和导致肠生态失调和/或提高肠细菌移位风险之疾病的患者中治疗疼痛的羟考酮与纳洛酮的组合

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2993836A (en) * 1958-02-20 1961-07-25 Dow Chemical Co Sustained release tablets
US2980589A (en) * 1958-09-12 1961-04-18 American Cyanamid Co Process for producing anhydrous granulation of a medicinally active waterlabile powder
US3079303A (en) * 1958-12-11 1963-02-26 Smith Kline French Lab Basic tablet granulation and process of using same
FR1473805A (fr) * 1959-10-01 1967-03-24 Merck & Co Inc Véhicule pharmaceutique
US3133863A (en) * 1961-03-10 1964-05-19 Strong Cobb Arner Inc Sustained release therapeutic tablet compositions comprising organic solvent-gelled gums
US3148124A (en) * 1962-06-12 1964-09-08 William E Gaunt Method of preparing sustained release pharmaceutical tablets
US3453360A (en) * 1966-04-27 1969-07-01 Abbott Lab Universally useful stock material for manufacturing plastic dosage units by compression tableting processes
US3577514A (en) * 1968-06-10 1971-05-04 Pfizer Sustained release pharmaceutical tablets
US3507952A (en) * 1968-12-20 1970-04-21 Smithkline Corp Sustained release bolus for animal husbandry
GB1359643A (en) * 1970-09-28 1974-07-10 Controlled Medications Controlled release medicament
US3773920A (en) * 1971-07-14 1973-11-20 Nikken Chemicals Co Ltd Sustained release medicinal composition
US3773921A (en) * 1971-11-15 1973-11-20 Hoffmann La Roche Therapeutic compositions

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5556639A (en) * 1991-01-30 1996-09-17 Glaxo Wellcome Inc. Water-dispersible tablets
US5629016A (en) * 1991-01-30 1997-05-13 Glaxo Wellcome Inc. Water-dispersible tablets
US5660860A (en) * 1991-01-30 1997-08-26 Glaxo Wellcome Inc. Water-dispersible tablets
US5698221A (en) * 1992-07-27 1997-12-16 Patel; Suryakant Dahyabhai Water-dispersible tablets
US5698226A (en) * 1993-07-13 1997-12-16 Glaxo Wellcome Inc. Water-dispersible tablets
US7585521B2 (en) 2000-02-21 2009-09-08 Australian Nuclear Science & Technology Organisation Controlled release ceramic particles, compositions thereof, processes of preparation and methods of use

Also Published As

Publication number Publication date
DE2323686A1 (de) 1973-11-22
DK137706B (da) 1978-04-24
CA1041906A (fr) 1978-11-07
US3950508A (en) 1976-04-13
JPS5526124B2 (US06486227-20021126-C00005.png) 1980-07-11
BE799331A (fr) 1973-11-09
NL7306422A (US06486227-20021126-C00005.png) 1973-11-13
AU5531473A (en) 1974-11-07
JPS4992217A (US06486227-20021126-C00005.png) 1974-09-03
DD104027A5 (US06486227-20021126-C00005.png) 1974-02-20
HU168307B (US06486227-20021126-C00005.png) 1976-03-28
OA04380A (fr) 1980-02-15
IL42232A0 (en) 1973-07-30
AR203268A1 (es) 1975-08-29
FI56623B (fi) 1979-11-30
IN139518B (US06486227-20021126-C00005.png) 1976-06-26
DK137706C (US06486227-20021126-C00005.png) 1982-11-15
FR2183546A1 (US06486227-20021126-C00005.png) 1973-12-21
FI56623C (fi) 1980-03-10
IL42232A (en) 1976-08-31
FR2183546B1 (US06486227-20021126-C00005.png) 1975-06-20
ZA733188B (en) 1975-01-29
NL158388B (nl) 1978-11-15

Similar Documents

Publication Publication Date Title
GB1421964A (en) Process for the production of sustained release pharmaceutical preparations
GB1471564A (en) Direct compression tabletting composition and tablets produced therefrom
KR930001831B1 (ko) 티아민 염 과립의 제조방법
GB1430684A (en) Prolonged release lozenges
US3101299A (en) Silica-gel powder tablet compositions
RU2002123182A (ru) Содержащая ибупрофен композиция
KR910011241A (ko) 정제로 직접 압착 가능한 약제학적 분말 조성물을 제조하기 위한 분무 건조법
ES422710A1 (es) Procedimiento para la produccion de granulos pesticidas dispersables en agua.
CA1199871A (en) Drug preparations for glycoside hydrolase inhibitors
WO1992008463A1 (fr) Procede de preparation par compression directe de comprimes de derives de l'acide cephalosporanique
KR880000871B1 (ko) 옥사졸 유도체의 제조방법
JPS6320409B2 (US06486227-20021126-C00005.png)
CA2352542A1 (en) Method for producing medicaments from plant extracts, in a solid form of administration
GB1506345A (en) Multitioned tablets
IE40599B1 (en) Tablet formulation
US3155577A (en) Tasteless dioctylsulfosuccinate composition and method of making same
PL331588A1 (en) Granulated products containing a water-soluble compound and cellulose
US6322812B1 (en) Pharmaceutical forms for the oral administration of mesna
AU663000B2 (en) Adsorbate of an auxiliary mixture and a non-solid active compound for the preparation of pharmaceutical compositions
GB2135191A (en) Medicaments containing muzolimine
US3524917A (en) Tablets of magnesium probenecid tetrahydrate
US3740432A (en) Vitamin complexes of niacinamide,riboflavin and sodium ascorbate
CA2413578C (en) Use of dicalcium phosphate anhydride powder
JPS61145111A (ja) アセトアミノフェン含有錠剤の製造方法
US5910320A (en) Tablet or capsule having a content of stable ranitidine hydrochloride form 1

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PCNP Patent ceased through non-payment of renewal fee